Lupin (LUPIN) — Financial Results

1 Financial Results 🔴 High Importance Neutral 📄 PDF

Lupin Limited disclosed Q1 FY26 earnings call details via regulatory filing on August 6, 2025. The company conducted a digital earnings call for the quarter ended June 30, 2025, with an audio recording made available on its website. This filing is a procedural disclosure under SEBI listing regulations and does not contain financial metrics or operational results.

2 Financial Results 🔴 High Importance ✨ Positive 📄 PDF

Lupin Limited reported Q1 FY26 net sales of ₹61,638 million, growing 11.8% YoY, with net income reaching ₹12,191 million, up 52.1% YoY. EBITDA margin expanded significantly to 26.6% from 23.3% in Q1 FY25. North America led growth at 23% YoY to ₹25,155 million, driven by new product launches including Tolvaptan with sole 180-day first-to-file exclusivity. India grew 8% YoY to ₹20,894 million. The company maintained complex generics leadership in the US (#3 ranking) and received key regulatory approvals including FDA authorization for Tolvaptan.

📊 Stock Analysis — LUPIN ✨ Ask AI About This

About Lupin Limited (LUPIN)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,04,071.47 Cr P/E: 36.2

View full LUPIN stock details →

📡 Get AI alerts when LUPIN files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track LUPIN — Free

💡 Ask AI about this filing

"How does this financial results affect Lupin Limited's outlook?" "What did Lupin Limited announce on 6 August 2025?" "Is this positive or negative for LUPIN?"

Ask AI Free →

📊 More LUPIN filings

See all LUPIN filings →

🔥 Also filed on 6 August 2025

RECLTD REC Limited Financial Results SUNPHARMA Sun Pharmaceutical Industries Limited Financial Results TATAPOWER Tata Power Company Limited Financial Results TATASTEEL Tata Steel Limited Announcement TATASTEEL Tata Steel Limited Financial Results TRENT Trent Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when LUPIN files new disclosures

Track LUPIN filings, board meetings, and corporate actions. Free email alerts at 5 PM.